VCCircle

MPM Capital, a US-based life sciences venture fund in which Reliance Life Sciences is a limited partner, is in the process of closing one or two investments in the next six months, says a Reuters report. In April this year, Reliance Life Sciences made an undisclosed investment in MPM BioVentures IV fund which has a corpus of $550 million. The firm runs the world's largest life sciences dedicated funds with about $2.5 billion under management.
Reuters quotes William Greene, one of its general partners, as saying: "We are beginning to focus on India and China...In the next months, I would like to see 1-2 investments in India ... about $20 million is the kind of byte size we are looking at."
The firm will look at "a broad spectrum of life sciences companies, especially those offering discovery outsourcing and contract research and manufacturing services". "Services in general are pretty interesting. Medical devices sector could be very interesting in the longer term," he has been quoted as saying. They will also look at companies in research and development focused on new molecules.

Related:
Reliance Life Sciences Invests In MPM Capital’s India Fund